Trilogy Global Advisors LP decreased its position in Express Scripts Holding Co. (NASDAQ:ESRX) by 5.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 557,728 shares of the company’s stock after selling 29,398 shares during the period. Express Scripts Holding accounts for about 1.3% of Trilogy Global Advisors LP’s investment portfolio, making the stock its 27th largest position. Trilogy Global Advisors LP owned approximately 0.09% of Express Scripts Holding worth $42,276,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. Nuveen Asset Management LLC increased its stake in Express Scripts Holding by 59.6% in the first quarter. Nuveen Asset Management LLC now owns 517,135 shares of the company’s stock worth $35,522,000 after buying an additional 193,030 shares in the last quarter. National Pension Service increased its stake in Express Scripts Holding by 4.2% in the first quarter. National Pension Service now owns 384,147 shares of the company’s stock worth $26,387,000 after buying an additional 15,505 shares in the last quarter. Amici Capital LLC increased its stake in Express Scripts Holding by 19.9% in the first quarter. Amici Capital LLC now owns 755,561 shares of the company’s stock worth $51,899,000 after buying an additional 125,500 shares in the last quarter. Allen Investment Management LLC increased its stake in Express Scripts Holding by 9.0% in the first quarter. Allen Investment Management LLC now owns 836,160 shares of the company’s stock worth $57,436,000 after buying an additional 69,162 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its stake in Express Scripts Holding by 15.0% in the second quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 64,547 shares of the company’s stock worth $4,893,000 after buying an additional 8,400 shares in the last quarter. Hedge funds and other institutional investors own 88.52% of the company’s stock.

Express Scripts Holding Co. (NASDAQ:ESRX) traded up 0.29% on Wednesday, hitting $69.45. The stock had a trading volume of 930,734 shares. Express Scripts Holding Co. has a one year low of $65.55 and a one year high of $89.20. The company’s 50-day moving average is $73.93 and its 200-day moving average is $73.68. The stock has a market cap of $43.77 billion, a P/E ratio of 17.16 and a beta of 1.31.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings results on Monday, July 25th. The company reported $1.57 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.57. Express Scripts Holding had a return on equity of 23.98% and a net margin of 2.64%. The company had revenue of $25.20 billion for the quarter, compared to analyst estimates of $25.42 billion. During the same quarter in the prior year, the company posted $1.44 EPS. The business’s revenue for the quarter was down .9% compared to the same quarter last year. On average, analysts anticipate that Express Scripts Holding Co. will post $6.37 earnings per share for the current fiscal year.

A number of equities research analysts have commented on ESRX shares. Jefferies Group restated a “buy” rating and issued a $88.00 target price on shares of Express Scripts Holding in a research report on Monday, August 29th. Sanford C. Bernstein restated an “underperform” rating and issued a $68.00 target price on shares of Express Scripts Holding in a research report on Tuesday, September 6th. Bank of America Corp. restated a “neutral” rating and issued a $82.00 target price on shares of Express Scripts Holding in a research report on Tuesday, June 7th. Zacks Investment Research raised Express Scripts Holding from a “hold” rating to a “buy” rating and set a $85.00 price objective for the company in a research note on Tuesday, June 7th. Finally, Cowen and Company reaffirmed a “positive” rating and issued a $83.00 price objective on shares of Express Scripts Holding in a research note on Wednesday, June 15th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $82.05.

In related news, VP Christopher A. Mcginnis sold 1,785 shares of the stock in a transaction on Monday, September 12th. The stock was sold at an average price of $70.77, for a total value of $126,324.45. Following the transaction, the vice president now directly owns 4,955 shares of the company’s stock, valued at approximately $350,665.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Woodrow A. Myers, Jr. sold 12,036 shares of the stock in a transaction on Wednesday, September 14th. The stock was sold at an average price of $70.40, for a total value of $847,334.40. Following the completion of the transaction, the director now directly owns 14,918 shares in the company, valued at $1,050,227.20. The disclosure for this sale can be found here. Company insiders own 0.54% of the company’s stock.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

5 Day Chart for NASDAQ:ESRX

Receive News & Ratings for Express Scripts Holding Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.